Opioids

All articles by Opioids

Documents reveal McKinsey’s role in fueling opioid crisis extended beyond Purdue
Documents reveal McKinsey’s role in fueling opioid crisis extended beyond Purdue
Lecia Bushak
June 30, 2022
2:38 pm

The just-revealed documents show the breadth of the consulting firm’s work with Endo Pharmaceuticals, Johnson & Johnson and Mallinckrodt on opioid marketing over the course of 15 years.

‘You poisoned our lives’: When opioid victims met with Purdue Pharma’s Sacklers
‘You poisoned our lives’: When opioid victims met with Purdue Pharma’s Sacklers
Marc Iskowitz
March 14, 2022
1:22 pm

About two dozen opioid victims aired grievances directly to three members of the Sackler family in a virtual hearing last week.

Federal jury: CVS, Walmart, Walgreens liable in opioid epidemic
Federal jury: CVS, Walmart, Walgreens liable in opioid epidemic
Lecia Bushak
November 23, 2021
4:58 pm

The three retail and pharmacy behemoths were found to have played a role in advancing the epidemic in two Ohio counties.

Only thing more shameful than Purdue’s misleading opioid marketing: Sacklers’ refusal to accept blame
Only thing more shameful than Purdue’s misleading opioid marketing: Sacklers’ refusal to accept blame
Marc Iskowitz
December 22, 2020
5:06 pm

Family members ducked responsibility for Purdue’s marketing misdeeds, despite exerting substantial oversight over the company’s management for many years.

Five things for pharma marketers to know: Friday, September 18, 2020
Five things for pharma marketers to know: Friday, September 18, 2020
Carrie Gavit
September 18, 2020
5:00 am

Moderna expects to know if COVID-19 vaccine is safe by Nov.; NY files opioid lawsuit against J&J; #WhoSavesTheirLives: An initiative advocating better support for HCPs.

Five things for pharma marketers to know: Wednesday, September 16, 2020
Five things for pharma marketers to know: Wednesday, September 16, 2020
Alison Kanski
September 16, 2020
5:00 am

Court upholds New York law requiring drugmakers to fund opioid programs; More Black and Hispanic children are dying from coronavirus; Eli Lilly’s rheumatoid arthritis drug helps speed recovery in COVID-19 patients.

Five things for pharma marketers to know: Wednesday, August 19, 2020
Five things for pharma marketers to know: Wednesday, August 19, 2020
Alison Kanski
August 19, 2020
5:00 am

States seeking $26.4 billion from J&J, distributors in opioid lawsuit; COVID-19 caused a mental health crisis; This year’s flu vaccine push could inform the COVID-19 vaccine effort.

Five things for pharma marketers to know: Tuesday, August 18, 2020
Five things for pharma marketers to know: Tuesday, August 18, 2020
Alison Kanski
August 18, 2020
5:00 am

States seek $2.2 trillion from Purdue Pharma; U.S. COVID-19 cases drop, but deaths rise; Opioid prescriptions decrease among Medicare Part D recipients.

Five things for pharma marketers to know: Monday, July 27, 2020
Five things for pharma marketers to know: Monday, July 27, 2020
Alison Kanski
July 27, 2020
5:00 am

Opioid labels must include information about naloxone; Three of four Americans support mask requirements; Submit a cover design for the MM&M Hall of Femme issue.

Five things for pharma marketers to know: Friday, July 17, 2020
Five things for pharma marketers to know: Friday, July 17, 2020
Alison Kanski
July 17, 2020
5:00 am

States cut opioid programs as overdoses spike; Novartis pledges to not profit from COVID-19 drugs sent to low-income countries; Walgreens partners with DoorDash to deliver over-the-counter drugs, health products.

  • From Our Partners